Status:
COMPLETED
Stability of the Microbiome in IBD and IBS
Lead Sponsor:
Medical University of Graz
Conditions:
Microbiota
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study the investigators aim to investigate the changes of the intestinal microbiome in three different cohorts (IBD, IBS, healthy) after applying the uniform disruptive factor of osmotic diarr...
Detailed Description
I
Eligibility Criteria
Inclusion
- patients with inflammatory bowel disease and irritable bowel syndrome and stable therapy since three months
- patients with the indication for colonoscopy
Exclusion
- age under 18
- pregnancy
- new therapy planned
- change of therapy within the last three months
- acute exacerbation of the inflammatory bowel disease
- colon pathologies of other origin: colocarcinoma, Illnesses with diarrhea (f.e.microscopic colitis), short bowel syndrome, malabsorption, colectomy
- intake of antibiotics in the last three months
- intake of probiotics in the last month
- intake of antibiotics or probiotics during the study
- new proton pump inhibitor therapy
- significant change of nutrition in the last three months
- holidays outside europe in the last month
- gastroenteritis in the last three months
- intake of laxatives
- nonsteroidal antiinflammatory drugs should be avoided and documented
Key Trial Info
Start Date :
August 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03395548
Start Date
August 25 2017
End Date
May 1 2020
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Graz
Graz, Styria, Austria, 8010